It has been reported that integrin subunit beta 3 (ITGB3) is positively related to a higher frequency of malignant melanomas than benign lesions, and insulin-like growth factor 1 receptor was found to be involved in adaptive bypass of BRAFV600E inhibition44,56. This evidence concerns the gene IGF1R and melanoma.